How important is Pfizer’s new COVID-19 antiviral likely to be? The US pharmaceutical company has said clinical trial results of its new COVID-19 pill are ‘game-changing’. Experts give newsGP their take on its likely impact.
‘We’re all going to get COVID’: What living with the virus may look like newsGP considers the implications of ‘living with COVID’.
New MBS items aim to help multidisciplinary care The Department of Health says the funding will help GPs work with other health disciplines to support vulnerable patients.
‘A complex decision’: COVID-19 vaccination and younger children The rollout of Pfizer for children aged 5–11 has been given the green light in the US. What is that likely to mean for vaccinators in Australia?
Vaccine hesitancy hits new low in Australia The downwards trend has been almost continuous for the past five months.
GPs to receive access to Moderna, DoH confirms The RACGP has welcomed the news, which will add another string to GPs’ bow in their efforts to vaccinate Australians against COVID.
Expanded role and funding for GPs in managing COVID-19 GPs will receive pulse oximeters and access to a new MBS item number in a plan designed to boost the role of primary care in managing the pandemic.
‘We need more support’: No extra funding for booster program A COVID-19 vaccine booster program has now been officially signed off, but GPs will miss out on additional remuneration for administering a third dose.
GPs to take central role in vaccine booster rollout What will the new COVID-19 vaccine booster program mean for general practices around the country?
What is the AY.4.2 COVID variant under investigation in the UK? The potentially more transmissible strain is descended from the main Delta variant and has already been identified in Australia.